Peptidylarginine deiminase and protein citrullination in prion diseases

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40; http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154326; PMID: 18233951
   PubMed Web of Science ®Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618 - 28; http://dx.doi.org/10.1016/S1474-4422(12)70063-7; PMID: 22710755
   PubMed Web of Science ®Google Scholar
• Jang B, Kim E, Choi JK, Jin JK, Kim JI, Ishigami A, et al. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol 2008; 173:1129 - 42; http://dx.doi.org/10.2353/ajpath.2008.080388; PMID: 18787103
   PubMed Web of Science ®Google Scholar
• Jang B, Jin JK, Jeon YC, Cho HJ, Ishigami A, Choi KC, et al. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2010; 119:199 - 210; http://dx.doi.org/10.1007/s00401-009-0625-x; PMID: 20013286
   PubMed Web of Science ®Google Scholar
• Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer’s disease. J Neurosci Res 2005; 80:120 - 8; http://dx.doi.org/10.1002/jnr.20431; PMID: 15704193
   PubMed Web of Science ®Google Scholar
• Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25:1106 - 18; http://dx.doi.org/10.1002/bies.10357; PMID: 14579251
   PubMed Web of Science ®Google Scholar
• Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 2004; 11:777 - 83; http://dx.doi.org/10.1038/nsmb799; PMID: 15247907
   PubMed Web of Science ®Google Scholar
• Méchin MC, Sebbag M, Arnaud J, Nachat R, Foulquier C, Adoue V, et al. Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int J Cosmet Sci 2007; 29:147 - 68; http://dx.doi.org/10.1111/j.1467-2494.2007.00377.x; PMID: 18489346
   PubMedGoogle Scholar
• Nachat R, Méchin MC, Charveron M, Serre G, Constans J, Simon M. Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages. J Invest Dermatol 2005; a 125:34 - 41; http://dx.doi.org/10.1111/j.0022-202X.2005.23763.x; PMID: 15982300
   PubMed Web of Science ®Google Scholar
• Nachat R, Méchin MC, Takahara H, Chavanas S, Charveron M, Serre G, et al. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005; b 124:384 - 93; http://dx.doi.org/10.1111/j.0022-202X.2004.23568.x; PMID: 15675958
   PubMed Web of Science ®Google Scholar
• Moscarello MA, Pritzker L, Mastronardi FG, Wood DD. Peptidylarginine deiminase: a candidate factor in demyelinating disease. J Neurochem 2002; 81:335 - 43; http://dx.doi.org/10.1046/j.1471-4159.2002.00834.x; PMID: 12064481
   PubMed Web of Science ®Google Scholar
• Shimada N, Handa S, Uchida Y, Fukuda M, Maruyama N, Asaga H, et al. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. J Neurosci Res 2010; 88:798 - 806; PMID: 19830834
   PubMed Web of Science ®Google Scholar
• Nicholas AP, Sambandam T, Echols JD, Tourtellotte WW. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol 2004; 473:128 - 36; http://dx.doi.org/10.1002/cne.20102; PMID: 15067723
   PubMed Web of Science ®Google Scholar
• Inagaki M, Takahara H, Nishi Y, Sugawara K, Sato C. Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. J Biol Chem 1989; 264:18119 - 27; PMID: 2808368
   PubMed Web of Science ®Google Scholar
• Musse AA, Li Z, Ackerley CA, Bienzle D, Lei H, Poma R, et al. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 2008; 1:229 - 40; http://dx.doi.org/10.1242/dmm.000729; PMID: 19093029
   PubMed Web of Science ®Google Scholar
• Lange S, Gögel S, Leung KY, Vernay B, Nicholas AP, Causey CP, et al. Protein deiminases: new players in the developmentally regulated loss of neural regenerative ability. Dev Biol 2011; 355:205 - 14; http://dx.doi.org/10.1016/j.ydbio.2011.04.015; PMID: 21539830
   PubMed Web of Science ®Google Scholar
• Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, et al. Histone deimination antagonizes arginine methylation. Cell 2004; 118:545 - 53; http://dx.doi.org/10.1016/j.cell.2004.08.020; PMID: 15339660
   PubMed Web of Science ®Google Scholar
• Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004; 306:279 - 83; http://dx.doi.org/10.1126/science.1101400; PMID: 15345777
   PubMed Web of Science ®Google Scholar
• Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009; 9:40; http://dx.doi.org/10.1186/1471-2407-9-40; PMID: 19183436
   PubMed Web of Science ®Google Scholar
• Yao H, Li P, Venters BJ, Zheng S, Thompson PR, Pugh BF, et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem 2008; 283:20060 - 8; http://dx.doi.org/10.1074/jbc.M802940200; PMID: 18499678
   PubMed Web of Science ®Google Scholar
• Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson PR, et al. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol 2008; 28:4745 - 58; http://dx.doi.org/10.1128/MCB.01747-07; PMID: 18505818
   PubMed Web of Science ®Google Scholar
• Li P, Wang D, Yao H, Doret P, Hao G, Shen Q, et al. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene 2010; 29:3153 - 62; http://dx.doi.org/10.1038/onc.2010.51; PMID: 20190809
   PubMed Web of Science ®Google Scholar
• Tanikawa C, Espinosa M, Suzuki A, Masuda K, Yamamoto K, Tsuchiya E, et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat Commun 2012; 3:676; http://dx.doi.org/10.1038/ncomms1676; PMID: 22334079
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009; 184:205 - 13; http://dx.doi.org/10.1083/jcb.200806072; PMID: 19153223
   PubMed Web of Science ®Google Scholar
• Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010; 207:1853 - 62; http://dx.doi.org/10.1084/jem.20100239; PMID: 20733033
   PubMed Web of Science ®Google Scholar
• Wright PW, Bolling LC, Calvert ME, Sarmento OF, Berkeley EV, Shea MC, et al. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol 2003; 256:73 - 88; http://dx.doi.org/10.1016/S0012-1606(02)00126-4; PMID: 12654293
   PubMed Web of Science ®Google Scholar
• Esposito G, Vitale AM, Leijten FP, Strik AM, Koonen-Reemst AM, Yurttas P, et al. Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol Cell Endocrinol 2007; 273:25 - 31; http://dx.doi.org/10.1016/j.mce.2007.05.005; PMID: 17587491
   PubMed Web of Science ®Google Scholar
• Yurttas P, Vitale AM, Fitzhenry RJ, Cohen-Gould L, Wu W, Gossen JA, et al. Role for PADI6 and the cytoplasmic lattices in ribosomal storage in oocytes and translational control in the early mouse embryo. Development 2008; 135:2627 - 36; http://dx.doi.org/10.1242/dev.016329; PMID: 18599511
   PubMed Web of Science ®Google Scholar
• Kan R, Yurttas P, Kim B, Jin M, Wo L, Lee B, et al. Regulation of mouse oocyte microtubule and organelle dynamics by PADI6 and the cytoplasmic lattices. Dev Biol 2011; 350:311 - 22; http://dx.doi.org/10.1016/j.ydbio.2010.11.033; PMID: 21147087
   PubMed Web of Science ®Google Scholar
• Jang B, Shin HY, Choi JK, Nguyen PT, Jeong BH, Ishigami A, et al. Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins. J Neuropathol Exp Neurol 2011; 70:116 - 24; http://dx.doi.org/10.1097/NEN.0b013e318207559e; PMID: 21343880
   PubMed Web of Science ®Google Scholar
• Bhattacharya SK, Crabb JS, Bonilha VL, Gu X, Takahara H, Crabb JW. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci 2006; 47:2508 - 14; http://dx.doi.org/10.1167/iovs.05-1499; PMID: 16723463
   PubMed Web of Science ®Google Scholar
• Moscarello MA, Wood DD, Ackerley C, Boulias C. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 1994; 94:146 - 54; http://dx.doi.org/10.1172/JCI117300; PMID: 7518827
   PubMed Web of Science ®Google Scholar
• Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008; 26:651 - 75; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090244; PMID: 18173373
   PubMed Web of Science ®Google Scholar
• Nicholas AP. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci Lett 2011; 495:26 - 9; http://dx.doi.org/10.1016/j.neulet.2011.03.028; PMID: 21414385
   PubMed Web of Science ®Google Scholar
• Wood DD, Bilbao JM, O’Connors P, Moscarello MA. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 1996; 40:18 - 24; http://dx.doi.org/10.1002/ana.410400106; PMID: 8687186
   PubMed Web of Science ®Google Scholar
• Moscarello MA, Mastronardi FG, Wood DD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 2007; 32:251 - 6; http://dx.doi.org/10.1007/s11064-006-9144-5; PMID: 17031564
   PubMed Web of Science ®Google Scholar
• Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 2000; 39:5374 - 81; http://dx.doi.org/10.1021/bi9925569; PMID: 10820008
   PubMed Web of Science ®Google Scholar
• Beniac DR, Wood DD, Palaniyar N, Ottensmeyer FP, Moscarello MA, Harauz G. Marburg’s variant of multiple sclerosis correlates with a less compact structure of myelin basic protein. Mol Cell Biol Res Commun 1999; 1:48 - 51; http://dx.doi.org/10.1006/mcbr.1999.0111; PMID: 10329477
   PubMedGoogle Scholar
• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376:1094 - 108; http://dx.doi.org/10.1016/S0140-6736(10)60826-4; PMID: 20870100
   PubMed Web of Science ®Google Scholar
• Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin MC, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007; 56:3541 - 53; http://dx.doi.org/10.1002/art.22983; PMID: 17968929
   PubMed Web of Science ®Google Scholar
• Chang X, Jian X, Yan X. Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis. Rheumatol Int 2009; 29:1337 - 42; http://dx.doi.org/10.1007/s00296-009-0863-1; PMID: 19194706
   PubMed Web of Science ®Google Scholar
• Chang X, Zhao Y, Sun S, Zhang Y, Zhu Y. The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 2009; 29:1411 - 6; http://dx.doi.org/10.1007/s00296-009-0870-2; PMID: 19199100
   PubMed Web of Science ®Google Scholar
• Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122:1791 - 802; http://dx.doi.org/10.1172/JCI60975; PMID: 22505457
   PubMed Web of Science ®Google Scholar
• Méchin MC, Enji M, Nachat R, Chavanas S, Charveron M, Ishida-Yamamoto A, et al. The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci 2005; 62:1984 - 95; http://dx.doi.org/10.1007/s00018-005-5196-y; PMID: 16091842
   PubMed Web of Science ®Google Scholar
• Knuckley B, Causey CP, Jones JE, Bhatia M, Dreyton CJ, Osborne TC, et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry 2010; 49:4852 - 63; http://dx.doi.org/10.1021/bi100363t; PMID: 20469888
   PubMed Web of Science ®Google Scholar
• Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012; 71:92 - 8; http://dx.doi.org/10.1136/ard.2011.151712; PMID: 21859690
   PubMed Web of Science ®Google Scholar
• Scemes E, Giaume C. Astrocyte calcium waves: what they are and what they do. Glia 2006; 54:716 - 25; http://dx.doi.org/10.1002/glia.20374; PMID: 17006900
   PubMed Web of Science ®Google Scholar
• Fiacco TA, McCarthy KD. Astrocyte calcium elevations: properties, propagation, and effects on brain signaling. Glia 2006; 54:676 - 90; http://dx.doi.org/10.1002/glia.20396; PMID: 17006896
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119:7 - 35; http://dx.doi.org/10.1007/s00401-009-0619-8; PMID: 20012068
   PubMed Web of Science ®Google Scholar
• Dong S, Kojima T, Shiraiwa M, Méchin MC, Chavanas S, Serre G, et al. Regulation of the expression of peptidylarginine deiminase type II gene (PADI2) in human keratinocytes involves Sp1 and Sp3 transcription factors. J Invest Dermatol 2005; 124:1026 - 33; http://dx.doi.org/10.1111/j.0022-202X.2005.23690.x; PMID: 15854045
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Lange ML. Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism. J Neurochem 2009; 111:915 - 33; http://dx.doi.org/10.1111/j.1471-4159.2009.06397.x; PMID: 19780894
   PubMed Web of Science ®Google Scholar
• Jang B, Jeon YC, Choi JK, Park M, Kim JI, Ishigami A, et al. Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases. Biochem J 2012; 445:183 - 92; PMID: 22551201
   PubMed Web of Science ®Google Scholar
• Vosler PS, Brennan CS, Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 2008; 38:78 - 100; http://dx.doi.org/10.1007/s12035-008-8036-x; PMID: 18686046
   PubMed Web of Science ®Google Scholar
• Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227:407 - 15; http://dx.doi.org/10.1111/j.1432-1033.1995.tb20403.x; PMID: 7851415
   PubMedGoogle Scholar
• Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, Lohmeyer J, et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009; 113:5588 - 98; http://dx.doi.org/10.1182/blood-2008-08-170837; PMID: 19182206
   PubMed Web of Science ®Google Scholar
• Young DS, Meersman F, Oxley D, Webster J, Gill AC, Bronstein I, et al. Effect of enzymatic deimination on the conformation of recombinant prion protein. Biochim Biophys Acta 2009; 1794:1123 - 33; http://dx.doi.org/10.1016/j.bbapap.2009.03.013; PMID: 19341825
   PubMed Web of Science ®Google Scholar